Therapeutic Potential of Marine Algae
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine-Derived Ingredients for Drugs, Cosmeceuticals and Nutraceuticals".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 68
Special Issue Editors
Interests: algae; natural products; bioactive function; bioprocess; genetic engineering
Interests: fucoxanthin; transcriptional regulation; Phaeodactylum tricornutum
Interests: tumor; drugs; resistance; therapeutic method; molecular mechanism
Special Issue Information
Dear colleagues,
As an important part of marine ecosystems, marine algae have rich and unique bioactive compounds. These compounds exhibit pharmacological effects such as anti-inflammatory, antioxidant, and antitumor properties. Their discovery has led to increased applications in medicine, notably in tumor therapy, immune regulation, and so on. With the improvement of biotechnology, metabolomics, and genomics, more and more active compounds are being discovered.
This Special Issue aims to comprehensively present the latest research progress and practical applications of marine algae in the therapeutic field, and invites articles focusing on the pharmacological properties and drug discovery of bioactive compounds derived from marine algae. We particularly welcome the articles that discover active compounds with therapeutic potential by using genomic, proteomic, and metabolomic methods.
Prof. Dr. Jianhua Fan
Dr. Xiaohui Li
Dr. Yingze Wei
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- marine algae
- therapeutic applications
- bioactive compounds
- pharmacological properties
- drug discovery
- genomics
- metabolomics
- biotechnology
- natural products
- pharmaceutical potential
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.